Carman Alenson's most recent trade in Prime Medicine Inc was a trade of 140,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prime Medicine Inc | Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2026 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 90,498 | 90,498 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 90,498 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 90,498 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 90,498 | 90,498 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 16,083 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 16,083 | 16,083 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 6,254 | 6,254 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 6,254 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 90,500 | 90,500 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Alenson Carman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 90,498 | 90,498 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 6,254 | 6,254 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Carman Alenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 90,498 | 90,498 | - | - | Stock Option (right to buy) |